PRESS RELEASE published on 09/18/2024 at 07:14, 4 days 3 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) CARMAT launches a capital increase of €10.3 million, extendable up to €13.6 million, with a subscription price of €1.60 per share to fund activities until at least 2024. Offering includes priority period for shareholders and global placement Financial Structure Capital Increase Subscription Price CARMAT Global Placement
PRESS RELEASE published on 09/06/2024 at 07:00, 16 days 3 hours ago Inside Information / News release on accounts, results CARMAT announces its 2024 half-year results, including €3.3M in sales, 20 Aeson® artificial heart implants, and reduction in cash-burn. The company also plans to achieve annual sales of €8-12M in 2024 and explores financing options Sales Financing CARMAT 2024 Results Aeson Heart
PRESS RELEASE published on 09/06/2024 at 07:00, 16 days 3 hours ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 09/03/2024 at 19:49, 18 days 14 hours ago Status of voting rights and capital of the company CARMAT Share Capital Voting Rights Equitization CARMAT Actions PACEO Financing
BRIEF published on 08/21/2024 at 18:05, 1 month ago Modification of the Rights Attached to the Categories of CARMAT Shares Share Capital Funding Action Right To Vote CARMAT
BRIEF published on 07/09/2024 at 07:05, 2 months 13 days ago CARMAT boosts its sales and affirms its development Business Development CARMAT Aeson® Locations EFICAS Study
PRESS RELEASE published on 07/09/2024 at 07:00, 2 months 13 days ago Inside Information / Other news releases CARMAT exceeds 2023 sales, with €3.2M revenue in H1 2024 & 20 Aeson® heart implants. Confidence in growth outlook maintained. EFICAS study progressing well Financial Results Sales Momentum CARMAT EFICAS Study Aeson Heart Implants
BRIEF published on 07/08/2024 at 07:05, 2 months 14 days ago CARMAT to Provide Half-Year Update on July 9, 2024 Financial Update CARMAT Artificial Heart Videoconference
PRESS RELEASE published on 07/08/2024 at 07:00, 2 months 14 days ago Inside Information / Other news releases CARMAT to provide a half-year update and host a videoconference in French on July 9, 2024. The update will cover advancements of the Aeson artificial heart and key company developments CARMAT Aeson Artificial Heart Videoconference Half-year Update Therapeutic Alternative
BRIEF published on 06/25/2024 at 07:05, 2 months 27 days ago New governance at CARMAT Governance Nomination Heart Failure CARMAT Pierre Bastid
Published on 09/20/2024 at 23:40, 1 day 11 hours ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 1 day 11 hours ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 1 day 11 hours ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 1 day 12 hours ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 1 day 12 hours ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/21/2024 at 11:57, 22 hours 50 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 09/20/2024 at 21:00, 1 day 13 hours ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 1 day 14 hours ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 1 day 14 hours ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 17:40, 1 day 17 hours ago Availability of the 2024 Half-Year Financial Report
Published on 09/19/2024 at 17:45, 2 days 17 hours ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)